Evidence supporting the use of: Puerain
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Puerarin is an isoflavone compound extracted from the root of Pueraria lobata (kudzu). It has a long history of use in traditional Chinese medicine, primarily for cardiovascular and neurological conditions. In relation to Parkinson’s Disease (PD), there is some emerging scientific interest. Preclinical studies, mostly in animal models and cell cultures, suggest that puerarin exhibits neuroprotective properties, possibly through antioxidative, anti-inflammatory, and anti-apoptotic mechanisms. For instance, several studies have shown that puerarin can attenuate dopaminergic neuronal loss in toxin-induced PD models, reduce oxidative stress markers, and modulate signaling pathways involved in cell survival. However, these findings are preliminary, and there is a lack of robust clinical trials in humans. While the animal data is promising and suggests a potential role for puerarin in slowing PD progression or alleviating symptoms, clinical efficacy and safety remain unproven. Consequently, although there is a scientific rationale and preclinical evidence for its use, the strength of evidence is low (rated 2/5), and puerarin should not be considered a validated or established therapy for Parkinson’s Disease at this time. More rigorous human studies are needed to determine its real-world benefit and safety profile in PD patients.

More about Puerain
More about Parkinson's Disease

Products containing Puerain

We currently have no products on Vitabase that contain this ingredient.